Paper42444360
Revisiting Insulin Resistance in the Pathophysiology of Type 2 Diabetes Mellitus: A Multi-Organ Perspective.
Lim S and 2 others. Diabetes Metab J, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Revisiting Insulin Resistance in the Pathophysiology of Type 2 Diabetes Mellitus: A Multi-Organ Perspective. Papers, record 42444360. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42444360
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Revisiting Insulin Resistance in the Pathophysiology of Type 2 Diabetes Mellitus: A Multi-Organ Perspective.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Insulin Resistance | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Humans | |
| Metabolic Syndrome | |
| Cardiovascular Diseases | |
| Animals |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Korea Health Industry Development Institute | PubMed | |||
| RS-2025-02214302 | Ministry of Health and Welfare | PubMed |
Source PubMed
References203
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25287287 | Branched-chain amino acids in metabolic signalling and insulin resistance. | Nat Rev Endocrinol | 2014 | https://conductscience.org/library/papers/25287287 | PubMed |
| 2 | 37840095 | Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. | Nat Med | 2023 | https://conductscience.org/library/papers/37840095 | PubMed |
| 3 | 38152989 | Metabolic Communication by SGLT2 Inhibition. | Circulation | 2024 | https://conductscience.org/library/papers/38152989 | PubMed |
| 4 | 27707707 | Insulin resistance in chronic kidney disease: a systematic review. | Am J Physiol Renal Physiol | 2016 | https://conductscience.org/library/papers/27707707 | PubMed |
| 5 | 31776781 | Thiazolidinediones: the Forgotten Diabetes Medications. | Curr Diab Rep | 2019 | https://conductscience.org/library/papers/31776781 | PubMed |
| 6 | 28045402 | Inflammatory mechanisms linking obesity and metabolic disease. | J Clin Invest | 2017 | https://conductscience.org/library/papers/28045402 | PubMed |
| 7 | 40249765 | Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes. | Diabetes Care | 2025 | https://conductscience.org/library/papers/40249765 | PubMed |
| 8 | 40137132 | The Functions of Major Gut Microbiota in Obesity and Type 2 Diabetes. | Metabolites | 2025 | https://conductscience.org/library/papers/40137132 | PubMed |
| 9 | 37385275 | Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. | Lancet | 2023 | https://conductscience.org/library/papers/37385275 | PubMed |
| 10 | 30731283 | Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. | Atherosclerosis | 2019 | https://conductscience.org/library/papers/30731283 | PubMed |
| 11 | 40825340 | Once-weekly semaglutide 2·4 mg in an Asian population with obesity, defined as BMI ≥25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial. | Lancet Diabetes Endocrinol | 2025 | https://conductscience.org/library/papers/40825340 | PubMed |
| 12 | 31081592 | A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium-glucose co-transporter-2 inhibitors. | Diabetes Obes Metab | 2019 | https://conductscience.org/library/papers/31081592 | PubMed |
| 13 | 30317615 | Insulin resistance: Review of the underlying molecular mechanisms. | J Cell Physiol | 2019 | https://conductscience.org/library/papers/30317615 | PubMed |
| 14 | 29223443 | Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes. | Clin Gastroenterol Hepatol | 2018 | https://conductscience.org/library/papers/29223443 | PubMed |
| 15 | 38650100 | Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism. | Diabetes Metab J | 2024 | https://conductscience.org/library/papers/38650100 | PubMed |
| 16 | 39231651 | Physiological and pathophysiological actions of insulin in the liver. | Endocr J | 2025 | https://conductscience.org/library/papers/39231651 | PubMed |
| 17 | 41358899 | 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026. | Diabetes Care | 2026 | https://conductscience.org/library/papers/41358899 | PubMed |
| 18 | 35468325 | Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial. | Lancet Diabetes Endocrinol | 2022 | https://conductscience.org/library/papers/35468325 | PubMed |
| 19 | 10102702 | Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. | Diabetes | 1999 | https://conductscience.org/library/papers/10102702 | PubMed |
| 20 | 31048405 | Accumulation of saturated intramyocellular lipid is associated with insulin resistance. | J Lipid Res | 2019 | https://conductscience.org/library/papers/31048405 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42941840 | SGLT2 Inhibition Combined with Zn Supplementation Protects the Liver-Pancreas Axis in Experimental Type 2 Diabetes. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941840 | PubMed |
| 42926917 | Comparative effects of aged and newly produced white tea on glucose and lipid metabolism and the gut microbiota in mice with high-fat diet-induced obesity. | Curr Res Food Sci | 2026 | https://conductscience.org/library/papers/42926917 | PubMed |
| 42883700 | Mitochondrial Dynamics in Diabetes Mellitus and Its Complications: Mechanisms, Pathological Roles, and Therapeutic Implications. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42883700 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42444360
GET https://conductscience.org/api/papers/v1/42444360/references?page=2